NYSE$CC
The Chemours · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Chemours reported solid fourth quarter results driven by strong performance in Titanium Technologies and Advanced Performance Materials, despite headwinds from logistics and raw material cost inflation.
Chemours reported a strong fourth quarter with net sales of $1.6 billion, up 18% year-over-year, and adjusted EBITDA of $307 million, up 25% year-over-year. The company's performance was driven by higher pricing and strong demand across its segments, particularly in Titanium Technologies and Advanced Performance Materials.
- Net sales increased by 18% year-over-year to $1.6 billion.
- Net income was $233 million, with EPS of $1.40, up $1.29 year-over-year.
- Adjusted EBITDA increased by 25% year-over-year to $307 million.
- The company completed the sale of Mining Solutions for $521 million.
Headline financials
Revenue & EPS history
Chemours · Revenue · Quarterly
$1.58B
Forward guidance
The company expects to deliver 2022 Adjusted EBITDA within a range of $1.3 billion to $1.425 billion. Adjusted EPS is projected to be between $4.07 and $4.70. The company expects Free Cash Flow of greater than $500 million, inclusive of approximately $400 million of capital expenditures.
Tailwinds
- Continued economic recovery from the challenges caused by the global pandemic
- Normalization of supply chains early in 2022
- Driving top-line growth
- Improving the underlying earnings quality of the business
- Capturing the significant secular growth potential of our core businesses
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2021
+1.4%
Avg return
Earnings day
+2.4%
Avg return
5 days after
+1.2%
Avg return
30 days after
55%
27 / 49 earnings
Positive
+24.2%
Q4 2019
Best reaction
-23.0%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -15.7% | -9.6% | -26.8% | |
| Q4 2025 | -16.5% | -11.7% | -13.3% | |
| Q3 2025 | +6.8% | +7.4% | +8.2% | |
| Q1 2025 | -9.4% | -0.9% | -8.1% | |
| Q4 2024 | +3.9% | -0.4% | -12.8% | |
| Q3 2024 | +11.6% | +11.1% | +19.4% | |
| Q2 2024 | -15.0% | -22.5% | -19.6% | |
| Q1 2024 | -6.1% | -4.0% | -7.6% | |
| Q4 2023 | -4.1% | +5.0% | -0.2% | |
| Q3 2023 | -0.1% | +2.1% | +11.7% | |
| Q2 2023 | -4.8% | -4.0% | -14.8% | |
| Q1 2023 | +6.4% | +11.1% | +4.4% | |
| Q4 2022 | -1.7% | -0.8% | -10.7% | |
| Q3 2022 | +1.0% | -0.9% | +13.5% | |
| Q2 2022 | +4.0% | +1.6% | +4.5% | |
| Q1 2022 | +17.7% | +21.1% | +31.7% | |
| Q4 2021 | -16.8% | -13.9% | -26.9% | |
| Q3 2021 | +8.0% | +4.7% | -3.0% | |
| Q2 2021 | +1.9% | +4.7% | +6.5% | |
| Q1 2021 | +4.4% | +14.7% | +23.0% | |
| Q4 2020 | -2.6% | -1.8% | +7.1% | |
| Q3 2020 | +2.2% | +8.3% | +23.0% | |
| Q2 2020 | -0.3% | +5.9% | +12.8% | |
| Q1 2020 | +12.9% | +18.3% | +44.4% | |
| Q4 2019 | +24.2% | +19.1% | -33.9% | |
| Q3 2019 | +13.9% | +13.4% | -11.1% | |
| Q2 2019 | -23.0% | -26.5% | -25.7% | |
| Q1 2019 | -1.8% | -16.4% | -39.4% | |
| Q4 2018 | -2.6% | -3.0% | -2.2% | |
| Q3 2018 | +4.1% | +2.9% | -13.7% | |
| Q2 2018 | +4.9% | +6.7% | -2.8% | |
| Q1 2018 | +4.5% | +4.4% | +1.7% | |
| Q4 2017 | +2.7% | +2.5% | +4.5% | |
| Q3 2017 | -8.4% | -10.5% | -9.0% | |
| Q2 2017 | -1.6% | +3.8% | +4.3% | |
| Q1 2017 | -1.0% | +2.4% | -0.7% | |
| Q4 2016 | -0.5% | +3.1% | +8.4% | |
| Q3 2016 | +12.7% | +21.1% | +52.3% | |
| Q2 2016 | +13.2% | +25.8% | +49.6% | |
| Q1 2015 | -3.1% | — | — | |
| Q1 2016 | +9.6% | — | — | |
| Q1 2014 | +2.3% | — | — | |
| Q4 2013 | +2.3% | — | — | |
| Q4 2015 | +14.3% | — | — | |
| Q3 2014 | -17.2% | — | — | |
| Q3 2015 | -17.2% | — | — | |
| Q4 2014 | +16.3% | — | — | |
| Q2 2014 | +16.3% | — | — | |
| Q2 2015 | +16.3% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro